Literature DB >> 23671731

CagA EPIYA polymorphisms in Colombian Helicobacter pylori strains and their influence on disease-associated cellular responses.

Carlos Alberto Fajardo1, Andrés Javier Quiroga, Andrea Coronado, Karen Labrador, Nicole Acosta, Pilar Delgado, Carlos Jaramillo, María Mercedes Bravo.   

Abstract

AIM: To investigate the influence of the CagA diversity in Helicobacter pylori (H. pylori) strains from Colombia on the host cell biology.
METHODS: Eighty-four H. pylori-cagA positive strains with different Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs patterns, isolated from patients with gastritis (n = 17), atrophic gastritis (n = 17), duodenal ulcer (n = 16), intestinal metaplasia (n = 16) and gastric cancer (n = 18), were included. To determine the integrity of the cag pathogenicity island (cagPAI) we evaluated the presence of cagA, cagT, cagE, and cag10 genes by polymerase chain reaction. AGS gastric epithelial cells were infected with each strain and assayed for translocation and tyrosine phosphorylation of CagA by western blot, secretion of interleukin-8 (IL-8) by enzyme-linked immuno sorbent assay after taking supernatants from cocultures and cell elongation induction. For cell elongation quantification, coculture photographs were taken and the proportion of "hummingbird" cells (> 15 μm) was determined.
RESULTS: Overall 72% (60/84) of the strains were found to harbor a functional cagPAI. Levels of phosphorylated CagA were significantly higher for isolates from duodenal ulcer than the ones in strains from gastritis, atrophic gastritis, intestinal metaplasia and gastric cancer (49.1% ± 23.1% vs 21.1% ± 19.5%, P < 0.02; 49.1% ± 23.1% vs 26.2% ± 14.8%, P < 0.045; 49.1% ± 23.1% vs 21.5% ± 19.5%, P < 0.043 and 49.1% ± 23.1% vs 29.5% ± 27.1%, P < 0.047 respectively). We observed variable IL-8 expression levels ranging from 0 to 810 pg/mL and from 8.8 to 1442 pg/mL at 6 h and 30 h post-infection, respectively. cagPAI-defective strains did not induce detectable levels of IL-8 at 6 h post-infection. At 30 h post-infection all strains induced IL-8 expression in AGS cells, although cagPAI-defective strains induced significantly lower levels of IL-8 than strains with a functional cagPAI (57.1 ± 56.6 pg/mL vs 513.6 ± 338.6 pg/mL, P < 0.0001). We did not observe differences in the extent of cell elongation induction between strains with a functional or a defective cagPAI in 6 h cocultures. At 24 h post infection strains with functional cagPAI showed high diversity in the extent of hummingbird phenotype induction ranging from 7% to 34%. cagPAI defective strains induced significantly lower levels of elongation than strains with functional cagPAI with one or more than one EPIYA-C motif (15.1% ± 5.2% vs 18.9% ± 4.7%, P < 0.03; and 15.1% ± 5.2% vs 20.0% ± 5.1%, P < 0.003 respectively). No differences were observed in cellular elongation induction or IL-8 expression among H. pylori strains bearing one and more than one EPIYA-C motifs, neither at 6 h nor at 24 h of coculture. There were no associations between the levels of induction of cell elongation or IL-8 expression and number of EPIYA motifs or pathology.
CONCLUSION: The present work describes a lack of association between H. pylori CagA protein EPIYA motifs variations from Colombian isolates and disease-associated cellular responses.

Entities:  

Keywords:  CagA protein; Cell elongation; Glu-Pro-Ile-Tyr-Ala; Helicobacter pylori; Interleukin 8; cagA 3’ region

Year:  2013        PMID: 23671731      PMCID: PMC3648663          DOI: 10.4251/wjgo.v5.i3.50

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  50 in total

1.  Variation in the number of EPIYA-C repeats in CagA protein from Colombian Helicobacter pylori strains and its ability middle to induce hummingbird phenotype in gastric epithelial cells.

Authors:  Andrés Javier Quiroga; Antonio Huertas; Alba Lucía Cómbita; María Mercedes Bravo
Journal:  Biomedica       Date:  2010 Apr-Jun       Impact factor: 0.935

2.  Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus.

Authors:  S Backert; E Ziska; V Brinkmann; U Zimny-Arndt; A Fauconnier; P R Jungblut; M Naumann; T F Meyer
Journal:  Cell Microbiol       Date:  2000-04       Impact factor: 3.715

3.  [BabA2, oipA and cagE Helicobacter pylori genotypes in Colombian patients with gastroduodenal diseases].

Authors:  Andrés Javier Quiroga; Diana Marcela Cittelly; María Mercedes Bravo
Journal:  Biomedica       Date:  2005-09       Impact factor: 0.935

4.  CagA and VacA polymorphisms are associated with distinct pathological features in Helicobacter pylori-infected adults with peptic ulcer and non-peptic ulcer disease.

Authors:  Effrosini G Panayotopoulou; Dionyssios N Sgouras; Konstantinos S Papadakos; Kalliopi Petraki; Sébastien Breurec; Spyros Michopoulos; Gerassimos Mantzaris; George Papatheodoridis; Andreas Mentis; Athanasios Archimandritis
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

5.  Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo.

Authors:  Matthias Selbach; Stefan Moese; Christof R Hauck; Thomas F Meyer; Steffen Backert
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

6.  Virulence-associated genotypes of Helicobacter pylori: do they explain the African enigma?

Authors:  Luis E Bravo; Leen-Jan van Doom; J Luis Realpe; Pelayo Correa
Journal:  Am J Gastroenterol       Date:  2002-11       Impact factor: 10.864

7.  NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein.

Authors:  Sabine Brandt; Terry Kwok; Roland Hartig; Wolfgang König; Steffen Backert
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-21       Impact factor: 11.205

8.  Investigation of the biological relevance of Helicobacter pylori cagE locus diversity, presence of CagA tyrosine phosphorylation motifs and vacuolating cytotoxin genotype on IL-8 induction in gastric epithelial cells.

Authors:  Robert J Owen; Sally Sharp; Andrew J Lawson; Zarmina Durrani; Sjoerd Rijpkema; Mark Kidd
Journal:  FEMS Immunol Med Microbiol       Date:  2003-05-25

9.  Functional association between the Helicobacter pylori virulence factors VacA and CagA.

Authors:  Richard H Argent; Rachael J Thomas; Darren P Letley; Michael G Rittig; Kim R Hardie; John C Atherton
Journal:  J Med Microbiol       Date:  2008-02       Impact factor: 2.472

10.  CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions.

Authors:  L A Sicinschi; P Correa; R M Peek; M C Camargo; M B Piazuelo; J Romero-Gallo; S S Hobbs; U Krishna; A Delgado; R Mera; L E Bravo; B G Schneider
Journal:  Clin Microbiol Infect       Date:  2009-05-15       Impact factor: 8.067

View more
  5 in total

Review 1.  At the Bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.

Authors:  Dana M Hardbower; Richard M Peek; Keith T Wilson
Journal:  J Leukoc Biol       Date:  2014-05-27       Impact factor: 4.962

2.  Five-year monitoring of considerable changes in tyrosine phosphorylation motifs of the Helicobacter pylori cagA gene in Iran.

Authors:  Mohammad Kargar; Sadegh Ghorbani-Dalini; Abbas Doosti; Akram Najafi
Journal:  J Appl Genet       Date:  2014-04-26       Impact factor: 3.240

Review 3.  Host pathogen interactions in Helicobacter pylori related gastric cancer.

Authors:  Magdalena Chmiela; Zuzanna Karwowska; Weronika Gonciarz; Bujana Allushi; Paweł Stączek
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

4.  cagA gene EPIYA motif genetic characterization from Colombian Helicobacter pylori isolates: Standardization of a molecular test for rapid clinical laboratory detection.

Authors:  Eliana Rocío Rodríguez Gómez; William Otero Regino; Pedro A Monterrey; Alba Alicia Trespalacios Rangel
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

5.  Structural Analysis of Variability and Interaction of the N-terminal of the Oncogenic Effector CagA of Helicobacter pylori with Phosphatidylserine.

Authors:  Cindy P Ulloa-Guerrero; Maria Del Pilar Delgado; Carlos A Jaramillo
Journal:  Int J Mol Sci       Date:  2018-10-22       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.